Healthcare

New Report: Transcriptomics Market is on the mark to reach Industry expectations

Transcriptomics Market by Technology (Microarray, Real-time PCR, and Sequencing Technology), Products & Services (Consumables, Instruments, Software, and Services), Application (Diagnostics & Disease Profiling, Drug Discovery, and Others), and End User (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, and Contract Research Organization)

Press Release

The Global Transcriptomics Market was valued at $3,212 million in 2016, and is projected to reach $7,954 million by 2023, growing at a CAGR of 13.8% from 2017 to 2023. Transcriptomics is the study of entire set of RNA transcripts produced by the genome of any organism. Increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and rise in application of transcriptomics, which includes drug discovery is expected to drive the growth of the transcriptomics market. In addition, rise in funding and grants by various private and government organizations have further stimulated the market growth. However, certain drawbacks of RNA sequencing and lack of skilled professionals are expected to restrain the market growth.

Increase in Research Funding

Thermo Fisher Scientific, Inc., initiated new Ion Torrent Transcriptome Profiling Grant Program, which focusses on the benefits of gene-level expression analysis as novel biomarkers, which can help in cancer diagnostics, prognostics, and experimental therapy use. The award included the use of the Ion AmpliSeq Transcriptome Technology by winners along with the help from Thermo Fisher Scientific’s Certified Service Provider partners.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2595

Presence in the U.S.

Most global manufacturers of transcriptomic systems, platforms, equipment, and technologies are active in North America, especially in the U.S. For instance, in April 2017, NuGEN Technologies, Inc. launched two new products, Universal Plus mRNA-Seq and Trio RNA-Seq kits that allows RNA sequencing with greater efficiency from routine samples.

The market is segmented based on technology, product & services, technology, application, end user, and region. Based on technology, it is divided into microarray, real time-PCR (qPCR), and sequencing. Based on products and services, the market is divided into consumables, instruments, software, and services. The application segment includes diagnostics & disease profiling, drug discovery, and others. The end users of this market include pharmaceutical & biotechnology companies, government institutes & academic centers, and contract research organization. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Fluidigm Corporation, and Promega Corporation.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/2595

Key Benefits

  • The study provides an in-depth analysis of the global transcriptomics market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Transcriptomics Market Key Segments:

By Technology

  • Real Time-PCR (qPCR)
  • Microarray
  • Sequencing
    • Sanger Sequencing
    • RNA-Sequencing

By Product & Services

  • Consumables
  • Instruments
  • Software
  • Services

By Application

  • Diagnostics & Disease Profiling
  • Drug Discovery
  • Others

End User

  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract research Organizations (CROs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    •  China
    •  India
    •  Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    •  Saudi Arabia
    •  South Africa
    •  Rest of LAMEA

For More Info on this Report, Visit @ https://www.prnewswire.com/news-releases/global-transcriptomics-market-expected-to-reach-7954-million-by-2023—allied-market-research-675814393.html#

Tags

Allied Market Research

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain. Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.

Related Articles

Close